The Diabetes Dish
The Diabetes Dish
OnTrackDiabetes.com
Episode 9: MannKind Corp's CCO Talks About the Benefits of Afrezza, Inhalable Insulin
29 minutes Posted Mar 9, 2017 at 7:05 pm.
0:00
29:53
Download MP3
Show notes

Mannkind Corporation is the first and currently only maker of inhalable insulin. Their CCO Michael Castagna, a PharmD, answers a bunch of questions about Afrezza, including how it works, why users like it, and what the concerns are around long-term side effects.